BioMed Research International / 2020 / Article / Tab 3 / Research Article
Valuable Role of Neutrophil CD64 and Highly Sensitive CRP Biomarkers for Diagnostic, Monitoring, and Prognostic Evaluations of Sepsis Patients in Neonatal ICUs Table 3 Comparison between nonsurvivor sepsis patients and survivor sepsis patients.
Nonsurvivor sepsis group Survivor sepsis group Median (IQR) Median (IQR) GA (weeks) 34 (32.75-37) 36 (34-38) -2.192 0.028 BW (grams) 2700 (2000-3200) 2580 (1900-3212.5) -0.076 0.939 Hb (g/dL) 11.15 (9.8-12) 13.1 (10.675-14.8) -3.507 <0.001 TLC (×109 /L) 10.65 (8.15-17.8) 14.6 (9.65-19.95) -2.17 0.03 ANC (×109 /L) 6.5 (2.4-12.4) 7 (4.4875-12.225) -1.11 0.267 Platelet (×109 /L) 90 (29-168) 240 (158-321.75) -5.252 <0.001 hs-CRP(mg/L) 24 (9.75-96) 12 (6-37) -2.368 0.018 CD64% 94.1 (83-97.6) 81.85 (60.075-89.375) -4.213 <0.001 CD64 MFI 2.15 (1.76-3) 1.82 (1.44-2.41) -2.958 0.003
GA: gestational age; BW: birth weight; Hb: hemoglobin; TLC: total leukocyte count; ANC: absolute neutrophil count; PLT: platelet; hs-CRP: highly sensitive CRP; nCD64%: neutrophil CD64%; nCD64MFI: nCD64 mean fluorescence intensity.